Skip to main content
Top
Published in: Abdominal Radiology 3/2017

01-03-2017

A practical imaging classification for the non-invasive differentiation of renal cell carcinoma into its main subtypes

Authors: Brindley David Cupido, Medica Sam, Sean David Winters, Bilal Ahmed, Michael Seidler, Guan Huang, Gavin Low

Published in: Abdominal Radiology | Issue 3/2017

Login to get access

Abstract

Aim

Renal cell carcinoma (RCC) is a heterogeneous disease which encompasses various subtypes that exhibit differing biologic behavior and imaging findings. Non-invasive subtype differentiation by imaging facilitates prognostication and treatment selection. The aim of the study was to evaluate the performance of a diagnostic imaging key based on tumor morphology, T2 signal intensity on MRI, and tumor vascularity for differentiating RCC into its subtypes.

Materials and methods

Using a custom-designed diagnostic imaging key, three blinded fellowship-trained abdominal radiologists independently evaluated the cross-sectional imaging of 50 histologically proven RCCs and categorized these into subtypes in two sessions. The diagnostic performance of the imaging key was evaluated and compared to the baseline performance without the key.

Results

The 50 RCCs comprised 20 (40%) clear cell, 17 (34%) papillary, and 13 (26%) chromophobe tumors. All expert readers demonstrated an improvement in diagnostic accuracy by an average of 5.3% with the use of the key. The readers showed good to excellent diagnostic performance for clear cell RCC (area under the receiver operating curve, AUROC of 0.86–0.91) and papillary RCC (AUROC of 0.82–0.87), and fair performance with chromophobe RCC (AUROC of 0.67–0.77). The Reader-to-SOR (standard of reference) agreement increased from 0.53 (moderate) to 0.67 (good) with the use of the key.

Conclusion

The diagnostic imaging key facilitates RCC subtype characterization and can be used as a decision support tool.
Literature
1.
go back to reference Gurel S, Narra V, Elsayes KM, et al. (2013) Subtypes of renal cell carcinoma: MRI and pathological features. Diagnost Interv Radiol 19(4):304–311. Gurel S, Narra V, Elsayes KM, et al. (2013) Subtypes of renal cell carcinoma: MRI and pathological features. Diagnost Interv Radiol 19(4):304–311.
2.
go back to reference Motzer RJ, Agarwal N, Beard C, et al. (2011) Kidney cancer. J Nat Compr Cancer Netw 9(9):960–977. Motzer RJ, Agarwal N, Beard C, et al. (2011) Kidney cancer. J Nat Compr Cancer Netw 9(9):960–977.
3.
go back to reference Sun MR, Ngo L, Genega EM, et al. (2009) Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes–correlation with pathologic findings. Radiology 250(3):793–802.CrossRefPubMed Sun MR, Ngo L, Genega EM, et al. (2009) Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes–correlation with pathologic findings. Radiology 250(3):793–802.CrossRefPubMed
4.
go back to reference Eble JN SG, Epstein JI, Sesterhenn IA (Eds.). (2004) World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. Lyon: IARC Press. Eble JN SG, Epstein JI, Sesterhenn IA (Eds.). (2004) World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. Lyon: IARC Press.
5.
go back to reference Lopez-Beltran A, Carrasco JC, Cheng L, et al. (2009) 2009 update on the classification of renal epithelial tumors in adults. Int J Urol 16(5):432–443.CrossRefPubMed Lopez-Beltran A, Carrasco JC, Cheng L, et al. (2009) 2009 update on the classification of renal epithelial tumors in adults. Int J Urol 16(5):432–443.CrossRefPubMed
6.
go back to reference Cheville JC, Lohse CM, Zincke H, Weaver AL, et al. (2003) Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol 27(5):612–624.CrossRefPubMed Cheville JC, Lohse CM, Zincke H, Weaver AL, et al. (2003) Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol 27(5):612–624.CrossRefPubMed
8.
go back to reference Margulis V, Tamboli P, Matin SF, et al. (2008) Analysis of clinicopathologic predictors of oncologic outcome provides insight into the natural history of surgically managed papillary renal cell carcinoma. Cancer 112(7):1480–1488.CrossRefPubMed Margulis V, Tamboli P, Matin SF, et al. (2008) Analysis of clinicopathologic predictors of oncologic outcome provides insight into the natural history of surgically managed papillary renal cell carcinoma. Cancer 112(7):1480–1488.CrossRefPubMed
9.
go back to reference Motzer RJ, Bacik J, Mariani T, et al. (2002) Treatment outcome and survival associated with metastatic renal cell carcinoma of non-clear-cell histology. J Clin Oncol 20(9):2376–2381.CrossRefPubMed Motzer RJ, Bacik J, Mariani T, et al. (2002) Treatment outcome and survival associated with metastatic renal cell carcinoma of non-clear-cell histology. J Clin Oncol 20(9):2376–2381.CrossRefPubMed
10.
go back to reference Amin MB, Amin MB, Tamboli P, et al. (2002) Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases. Am J Surg Pathol 26(3):281–291.CrossRefPubMed Amin MB, Amin MB, Tamboli P, et al. (2002) Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases. Am J Surg Pathol 26(3):281–291.CrossRefPubMed
11.
go back to reference Prasad SR, Humphrey PA, Catena JR (2006) Common and uncommon histologic subtypes of renal cell carcinoma: imaging spectrum with pathologic correlation. Radiographics 26((6):1795–1806 (discussion 1806–1710).CrossRefPubMed Prasad SR, Humphrey PA, Catena JR (2006) Common and uncommon histologic subtypes of renal cell carcinoma: imaging spectrum with pathologic correlation. Radiographics 26((6):1795–1806 (discussion 1806–1710).CrossRefPubMed
12.
go back to reference Young JR, Margolis D, Sauk S, et al. (2013) Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT. Radiology 267(2):444–453.CrossRefPubMed Young JR, Margolis D, Sauk S, et al. (2013) Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT. Radiology 267(2):444–453.CrossRefPubMed
13.
go back to reference Vikram R, Ng CS, Tamboli P, et al. (2009) Papillary renal cell carcinoma: radiologic-pathologic correlation and spectrum of disease. Radiographics 29(3):741–754 (discussion 755–747).CrossRefPubMed Vikram R, Ng CS, Tamboli P, et al. (2009) Papillary renal cell carcinoma: radiologic-pathologic correlation and spectrum of disease. Radiographics 29(3):741–754 (discussion 755–747).CrossRefPubMed
14.
go back to reference Ramamurthy NK, Moosavi B, McInnes MD, et al. (2015) Multiparametric MRI of solid renal masses: pearls and pitfalls. Clin Radiol 70(3):304–316.CrossRefPubMed Ramamurthy NK, Moosavi B, McInnes MD, et al. (2015) Multiparametric MRI of solid renal masses: pearls and pitfalls. Clin Radiol 70(3):304–316.CrossRefPubMed
15.
go back to reference Lee-Felker SA, Felker ER, Tan N, et al. (2014) Qualitative and quantitative MDCT features for differentiating clear cell renal cell carcinoma from other solid renal cortical masses. AJR Am J Roentgenol 203(5):W516–W524.CrossRefPubMed Lee-Felker SA, Felker ER, Tan N, et al. (2014) Qualitative and quantitative MDCT features for differentiating clear cell renal cell carcinoma from other solid renal cortical masses. AJR Am J Roentgenol 203(5):W516–W524.CrossRefPubMed
16.
go back to reference Oliva MR, Glickman JN, Zou KH, et al. (2009) Renal cell carcinoma: T1 and T2 signal intensity characteristics of papillary and clear cell types correlated with pathology. AJR Am J Roentgenol 192(6):1524–1530.CrossRefPubMed Oliva MR, Glickman JN, Zou KH, et al. (2009) Renal cell carcinoma: T1 and T2 signal intensity characteristics of papillary and clear cell types correlated with pathology. AJR Am J Roentgenol 192(6):1524–1530.CrossRefPubMed
17.
go back to reference Ren A, Cai F, Shang YN, et al. (2015) Differentiation of renal oncocytoma and renal clear cell carcinoma using relative CT enhancement ratio. Chin Med J 128(2):175–179.CrossRefPubMedPubMedCentral Ren A, Cai F, Shang YN, et al. (2015) Differentiation of renal oncocytoma and renal clear cell carcinoma using relative CT enhancement ratio. Chin Med J 128(2):175–179.CrossRefPubMedPubMedCentral
18.
go back to reference Rosenkrantz AB, Hindman N, Fitzgerald EF, et al. (2010) MRI features of renal oncocytoma and chromophobe renal cell carcinoma. AJR Am J Roentgenol 195(6):W421–W427.CrossRefPubMed Rosenkrantz AB, Hindman N, Fitzgerald EF, et al. (2010) MRI features of renal oncocytoma and chromophobe renal cell carcinoma. AJR Am J Roentgenol 195(6):W421–W427.CrossRefPubMed
19.
go back to reference Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33(1):159–174.CrossRefPubMed Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33(1):159–174.CrossRefPubMed
20.
go back to reference Bielecka ZF, Czarnecka AM, Szczylik C (2014) Genomic analysis as the first step toward personalized treatment in renal cell carcinoma. Front Oncol 4:194.CrossRefPubMedPubMedCentral Bielecka ZF, Czarnecka AM, Szczylik C (2014) Genomic analysis as the first step toward personalized treatment in renal cell carcinoma. Front Oncol 4:194.CrossRefPubMedPubMedCentral
21.
go back to reference Hollingsworth JM, Miller DC, Daignault S, Hollenbeck BK (2006) Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst 98(18):1331–1334.CrossRefPubMed Hollingsworth JM, Miller DC, Daignault S, Hollenbeck BK (2006) Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst 98(18):1331–1334.CrossRefPubMed
22.
go back to reference Low G, Huang G, Fu W, Moloo Z, Girgis S (2016) Review of renal cell carcinoma and its common subtypes in radiology. W J Radiol 8(5):484–500.CrossRef Low G, Huang G, Fu W, Moloo Z, Girgis S (2016) Review of renal cell carcinoma and its common subtypes in radiology. W J Radiol 8(5):484–500.CrossRef
23.
go back to reference Kim JK, Kim TK, Ahn HJ, et al. (2002) Differentiation of subtypes of renal cell carcinoma on helical CT scans. AJR Am J Roentgenol 178(6):1499–1506.CrossRefPubMed Kim JK, Kim TK, Ahn HJ, et al. (2002) Differentiation of subtypes of renal cell carcinoma on helical CT scans. AJR Am J Roentgenol 178(6):1499–1506.CrossRefPubMed
24.
go back to reference Ho VB, Choyke PL (2004) MR Evaluation of solid renal masses. Magn Reson Imaging Clin N Am 12(3):413–427.CrossRefPubMed Ho VB, Choyke PL (2004) MR Evaluation of solid renal masses. Magn Reson Imaging Clin N Am 12(3):413–427.CrossRefPubMed
Metadata
Title
A practical imaging classification for the non-invasive differentiation of renal cell carcinoma into its main subtypes
Authors
Brindley David Cupido
Medica Sam
Sean David Winters
Bilal Ahmed
Michael Seidler
Guan Huang
Gavin Low
Publication date
01-03-2017
Publisher
Springer US
Published in
Abdominal Radiology / Issue 3/2017
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-016-0940-3

Other articles of this Issue 3/2017

Abdominal Radiology 3/2017 Go to the issue

Classics in Abdominal Imaging

The “erased charcoal” sign

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.